IDiyas

For the Inventor, By the Inventor

Somerset, NJ, United States of America

Gordon E Olsen

USPTO Granted Patents = 36

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 258(Granted Patents)


Location History:

  • Somerset, NJ (US) (1989 - 1997)
  • Las Vegas, NV (US) (2006)

Company Filing History:

goldMedal32 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal2 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal2 out of 832,680 
Other
 patents

Years Active: 1989-2006

Loading Chart...
36 patents (USPTO):Explore Patents
1. 7001033 - Image display device (2006-02-21),
2. 5688816 - Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs (1997-11-18),
3. 5519131 - Synthesis of pyridooxazinyl-indoles (1996-05-21),
4. 5455245 - Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs (1995-10-03),
5. 5405856 - Certain nitro-3-pyrinamines and 3-oxy-analogues (1995-04-11),
6. 5276156 - N-(halopyridin-4-yl)-N-substituted compounds as intermediates in the (1994-01-04),
7. 5264442 - Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs (1993-11-23),
8. 5221682 - Heteroarylamino- and heteroaryloxypyridinamines and related compounds (1993-06-22),
9. 5214058 - 1-(pyridinylalkyl)-1H-indoles, indolines and related analogs (1993-05-25),
10. 5214038 - 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the (1993-05-25),
11. 5212184 - 1-substituted-4-pentafluorophenoxypiperidines (1993-05-18),
12. 5192776 - 1-subsituted-4-pentafluorophenoxypiperidines (1993-03-09),
13. 5179204 - N-substituted-4-pyrimidinamines and pyrimidinediamines (1993-01-12),
14. 5102891 - 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates (1992-04-07),
15. 5039811 - Preparation of N-(pyridinyl)-1H-indol-1-amines (1991-08-13),

Title: The Innovative Contributions of Gordon E Olsen

Introduction: Gordon E Olsen, based in Somerset, NJ, is a prolific inventor with an impressive portfolio of 35 patents. His work primarily focuses on compounds that address significant medical conditions, showcasing his dedication to advancing pharmaceutical sciences.

Latest Patents: Among his latest contributions, Olsen's patent titled "Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs" stands out. This invention pertains to compounds that are useful in treating various memory dysfunctions, particularly those associated with cholinergic deficits, and may hold potential in the treatment of Alzheimer's disease. Another noteworthy patent is the "Synthesis of pyridooxazinyl-indoles," which describes a process for synthesizing indolylpyridooxazines utilizing strong bases, such as sodium hydride or potassium t-butoxide, to facilitate cyclization.

Career Highlights: Throughout his career, Olsen has made significant contributions to the pharmaceutical industry, notably while working at Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His innovative spirit and expertise have cemented his reputation as a key figure in pharmaceutical research and development.

Collaborations: Collaborating with industry professionals has been part of Olsen's journey. Notable coworkers include Larry A Davis and Richard C Effland, who have shared insights and expertise throughout various projects. These collaborations have undoubtedly enriched the innovation process and led to impactful advancements in their respective fields.

Conclusion: Gordon E Olsen's extensive patent portfolio and contributions to the pharmaceutical industry illustrate a remarkable commitment to innovation. His work continues to influence the development of treatments that address critical health issues, reflecting the vital role inventors play in shaping our world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…